The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate.

Perez-Simón, Jose Antonio

The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate. [electronic resource] - Haematologica Apr 2013 - 526-32 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study

1592-8721

10.3324/haematol.2012.065599 doi


Adult
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Combined Modality Therapy
Cyclosporine--administration & dosage
Disease-Free Survival
Female
Gastrointestinal Diseases--chemically induced
Graft vs Host Disease--etiology
Hematologic Neoplasms--mortality
Hematopoietic Stem Cell Transplantation--adverse effects
Humans
Infections--chemically induced
Male
Middle Aged
Mycophenolic Acid--administration & dosage
Prospective Studies
Sirolimus--administration & dosage
Survival Rate
Tacrolimus--administration & dosage
Time Factors
Transplantation Conditioning--adverse effects
Transplantation, Homologous
Treatment Outcome
Unrelated Donors
Young Adult